Case number 1:20-cv-00516
Astellas US LLC et al v. Glenmark Pharmaceuticals Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 12, 2021 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. 756 in Lead C.A. No. 18-1675-CFC-CJB. (fms) |
| Aug 6, 2020 | 19 | Redacted Document (8) Docket Text: REDACTED VERSION of [18] Stipulation by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Aug 3, 2020 | N/A | Remark (0) Docket Text: Any future filings shall be made in C.A. No.18-1675-CFC (fms) |
| Aug 3, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01675-CFC-CJB. (fms) |
| Aug 3, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (18 in 1:20-cv-00516-CFC) SEALED Stipulation filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Ordered by Judge Colm F. Connolly on 8/3/2020. Associated Cases: 1:20-cv-00516-CFC, 1:18-cv-01675-CFC-CJB(fms) |
| Jul 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] STIPULATION TO EXTEND TIME Proposed Scheduling Order to July 31, 2020 filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 7/24/2020. (nmf) |
| Jul 23, 2020 | 17 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Proposed Scheduling Order to July 31, 2020 - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 17, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [16] MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Brittany B. Amadi and Kevin M. Yurkerwich filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. Signed by Judge Colm F. Connolly on 7/17/2020. (nmf) |
| Jul 16, 2020 | 16 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Brittany B. Amadi and Kevin M. Yurkerwich - filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Jul 16, 2020 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Telephone Conference held on 7/16/2020. (Court Reporter V. Gunning.) On or before July 23, 2020, the parties shall confer and submit an agreed upon proposed scheduling order. If the parties are unable to reach agreement, they shall file competing proposals. (nmf) |
| Jul 9, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER Rescheduling Teleconference, Due to a conflict in the Court's schedule, The Telephone Conference is rescheduled for 7/16/2020 at 01:30 PM before Judge Colm F. Connolly. Counsel for Plaintiffs shall coordinate the call and email the dial-in information to chambers. Ordered by Judge Colm F. Connolly on 7/9/2020. (nmf) |
| Jun 23, 2020 | 15 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First set of Requests for Production of Documents and Things to Defendant Glenmark Pharmaceuticals Limited filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 22, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [13] Letter, [14] Letter, ORDER Setting Teleconference: Counsel for Plaintiffs to coordinate the call and email the dial-in information to chambers: A Telephone Conference is set for 7/14/2020 at 10:30 AM before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 6/22/2020. (nmf) |
| Jun 18, 2020 | 14 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from James S. Green, Jr., Esq. regarding Consolidation. (Green, James) |
| Jun 16, 2020 | 13 | Letter (1) Docket Text: Letter to Honorable Colm F. Connolly from Robert M. Oakes regarding consolidation impasse. (Oakes, Robert) |
| Jun 11, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kimberly A. Kennedy for Glenmark Pharmaceuticals Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jun 11, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ben Katzenellebogen for Glenmark Pharmaceuticals Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jun 11, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Joseph M. Reisman for Glenmark Pharmaceuticals Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jun 11, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney William R. Zimmerman for Glenmark Pharmaceuticals Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jun 10, 2020 | 12 | Answer to Counterclaim (8) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim to Defendant's Counterclaim by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Jun 8, 2020 | 10 | Certificate of Service (1) |
| Jun 8, 2020 | 10 | Main Document (18) Docket Text: ANSWER to [1] Complaint, of Glenmark Pharmaceuticals Limited, COUNTERCLAIM against All Plaintiffs by Glenmark Pharmaceuticals Limited. (Attachments: # (1) Certificate of Service)(Green, James) |
| Jun 8, 2020 | 11 | Main Document (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Glenmark Pharmaceuticals Limited. (Attachments: # (1) Certificate of Service)(Green, James) |
| Jun 8, 2020 | 11 | Certificate of Service (1) |
| Jun 2, 2020 | 9 | Certification of William R. Zimmerman (1) |
| Jun 2, 2020 | 9 | Certification of Joseph Reisman (1) |
| Jun 2, 2020 | 9 | Certification of Ben Katzenellebogen (1) |
| Jun 2, 2020 | 9 | Certification of Kimberly Kennedy (1) |
| Jun 2, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [9] MOTION for Pro Hac Vice Appearance of Attorney Ben Katzenellebogen, Joseph Reisman, Kimberly A. Kennedy and William R. Zimmerman filed by Glenmark Pharmaceuticals Limited. Signed by Judge Colm F. Connolly on 6/2/2020. (fms) |
| Jun 2, 2020 | 9 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ben Katzenellebogen, Joseph Reisman, Kimberly A. Kennedy and William R. Zimmerman - filed by Glenmark Pharmaceuticals Limited. (Attachments: # (1) Certification of Ben Katzenellebogen, # (2) Certification of Joseph Reisman, # (3) Certification of Kimberly Kennedy, # (4) Certification of William R. Zimmerman)(Green, James) |
| May 6, 2020 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendant to move, answer, or otherwise respond to the Complaint to June 8, 2020 - filed by Glenmark Pharmaceuticals Limited. (Green, James) |
| May 6, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] STIPULATION TO EXTEND TIME for Defendant to move, answer, or otherwise respond to the Complaint to June 8, 2020 filed by Glenmark Pharmaceuticals Limited, Set/Reset Answer Deadlines: Glenmark Pharmaceuticals Limited answer due 6/8/2020. Signed by Judge Colm F. Connolly on 5/6/2020. (fms) |
| Apr 22, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Apr 17, 2020 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Astellas US LLC, Gilead Sciences, Inc., Astellas Pharma US, Inc.. Glenmark Pharmaceuticals Limited served on 4/17/2020, answer due 5/8/2020. (Oakes, Robert) |
| Apr 16, 2020 | N/A | No Summons Issued (0) Docket Text: No Summons Issued. (mal) |
| Apr 15, 2020 | 1 | Main Document (13) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Glenmark Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2900469.) - filed by Astellas US LLC, Gilead Sciences, Inc., Astellas Pharma US, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Civil Cover Sheet)(mal) |
| Apr 15, 2020 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc.. (mal) |
| Apr 15, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC. Astellas Pharma Inc. is the sole shareholder of Astellas US Holding, Inc. filed by Astellas Pharma US, Inc., Astellas US LLC. (mal) |
| Apr 15, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE 47,301 E ;US 8,524,883. (mal) |
| Apr 15, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: April 2, 2020. Date of Expiration of Patent: February 2, 2027.Thirty Month Stay Deadline: October 2, 2022. (mal) |
| Apr 15, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Apr 15, 2020 | 1 | Civil Cover Sheet (1) |
| Apr 15, 2020 | 1 | Exhibit D (18) |
| Apr 15, 2020 | 1 | Exhibit C (20) |
| Apr 15, 2020 | 1 | Exhibit B (22) |
| Apr 15, 2020 | 1 | Exhibit A (22) |
| Apr 15, 2020 | 1 | Complaint* (1) |
